Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Salmeterol, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Salmeterol impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Salmeterol-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Salmeterol-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Salmeterol Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (±)-Salmeterol-d3 Xinafoate (3-hydroxymethyl-d2;α-d1) | Stable Isotopes | CS-C-00682 | 94749-08-3(Unlabelled) | Enquire |
| alpha-Hydroxy salmeterol-d3 | Stable Isotopes | CS-O-56869 | 52405-02-2 (Unlabelled) | Enquire |
| Salmeterol EP Impurity A-d3 | Stable Isotopes | CS-T-98898 | 2714417-16-8 | Enquire |
| Salmeterol Xinafoate D3 | Stable Isotopes | CS-EO-02578 | Not Available | Enquire |
| Salmeterol Xinafoate-d3 | Stable Isotopes | CS-O-10454 | 94749-08-3(Unlabeled) | Enquire |
| Salmeterol-d12 Xinafoate | Stable Isotopes | CS-O-03089 | 94749-08-3 (Unlabeled) | In Stock |
| Salmeterol-d3 | Stable Isotopes | CS-O-03000 | 497063-94-2 | In Stock |
| Salmeterol-d4 | Stable Isotopes | CS-T-86154 | 1204192-41-5 | Enquire |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Salmeterol | API Standards | CS-T-85804 | 89365-50-4 | In Stock |
| Salmeterol Xinafoate | API Standards | CS-O-00305 | 94749-08-3 | In Stock |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (4-(benzyloxy)-1,3-phenylene)dimethanol | Impurities | CS-O-35992 | 63295-95-4 | Enquire |
| alpha-Hydroxysalmeterol | Impurities | CS-ED-01028 | 152405-02-2 | Enquire |
| dimethyl 4-(benzyloxy)isophthalate | Impurities | CS-ED-00810 | 63295-94-3 | Enquire |
| N-Nitroso Salmeterol | Impurities | CS-O-39042 | 3036581-81-1 | In Stock |
| Salmeterol Dibenzyl impurity | Impurities | CS-O-59738 | Not Available | Enquire |
| Salmeterol Dimer Impurity | Impurities | CS-O-08130 | 1391051-88-9 | In Stock |
| Salmeterol EP Impurity A | Impurities | CS-O-08124 | 1798014-51-3 | Enquire |
| Salmeterol EP Impurity B | Impurities | CS-O-08125 | 94749-02-7 | Enquire |
| Salmeterol EP Impurity C | Impurities | CS-O-08126 | 94749-11-8 | Enquire |
| Salmeterol EP Impurity C Oxalate salt | Impurities | CS-O-34250 | 94749-11-8 (Free base) | Enquire |
| Salmeterol EP Impurity D | Impurities | CS-O-08127 | 1391052-04-2 | Enquire |
| Salmeterol EP Impurity E | Impurities | CS-O-08128 | 108928-81-0 | Enquire |
| Salmeterol EP Impurity E 1-hydroxy-2-naphthoic acid salt | Impurities | CS-EO-03849 | 108928-81-0 (Freebase) | Enquire |
| Salmeterol EP Impurity F | Impurities | CS-O-08129 | 1391054-40-2 | Enquire |
| Salmeterol EP Impurity G | Impurities | CS-O-44344 | 2470130-36-8 | Enquire |
| Salmeterol Fluticasone Propionate Mixture | Impurities | CS-T-61226 | 136112-01-1 | Enquire |
| Salmeterol Impurity 1 HCl | Impurities | CS-O-56791 | Not Available | Enquire |
| Salmeterol Impurity 15 | Impurities | CS-O-56522 | 65843-60-9 | Enquire |
| Salmeterol Impurity 25 | Impurities | CS-O-36788 | 92900-77-1 | Enquire |
| Salmeterol Related Compound H | Impurities | CS-O-52111 | Not Available | Enquire |
| Salmeterol USP Related Compound H | Impurities | CS-O-08132 | 1330076-52-2 | Enquire |